PortfoliosLab logoPortfoliosLab logo
SWAV vs. DOCS
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

SWAV vs. DOCS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ShockWave Medical, Inc. (SWAV) and Doximity, Inc. (DOCS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

SWAV vs. DOCS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
SWAV
ShockWave Medical, Inc.
0.00%0.00%75.67%-7.32%15.30%-7.48%
DOCS
Doximity, Inc.
-47.38%-17.06%90.41%-16.45%-33.05%-5.42%

Fundamentals

Total Revenue (TTM)

SWAV:

$787.97M

DOCS:

$637.78M

Gross Profit (TTM)

SWAV:

$685.44M

DOCS:

$572.39M

EBITDA (TTM)

SWAV:

$204.51M

DOCS:

$268.45M

Returns By Period


SWAV

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

DOCS

1D
-1.81%
1M
-5.01%
YTD
-47.38%
6M
-68.15%
1Y
-59.85%
3Y*
-10.39%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SWAV vs. DOCS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SWAV

DOCS
DOCS Risk / Return Rank: 44
Overall Rank
DOCS Sharpe Ratio Rank: 22
Sharpe Ratio Rank
DOCS Sortino Ratio Rank: 22
Sortino Ratio Rank
DOCS Omega Ratio Rank: 33
Omega Ratio Rank
DOCS Calmar Ratio Rank: 99
Calmar Ratio Rank
DOCS Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SWAV vs. DOCS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ShockWave Medical, Inc. (SWAV) and Doximity, Inc. (DOCS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

SWAV vs. DOCS - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


SWAVDOCSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.22

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

Correlation

The correlation between SWAV and DOCS is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

SWAV vs. DOCS - Dividend Comparison

Neither SWAV nor DOCS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SWAV vs. DOCS - Drawdown Comparison


Loading graphics...

Drawdown Indicators


SWAVDOCSDifference

Max Drawdown

Largest peak-to-trough decline

-80.53%

Max Drawdown (1Y)

Largest decline over 1 year

-68.98%

Current Drawdown

Current decline from peak

-77.16%

Average Drawdown

Average peak-to-trough decline

-56.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

33.02%

Volatility

SWAV vs. DOCS - Volatility Comparison


Loading graphics...

Volatility by Period


SWAVDOCSDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.80%

Volatility (6M)

Calculated over the trailing 6-month period

37.71%

Volatility (1Y)

Calculated over the trailing 1-year period

49.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

68.77%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

68.77%

Financials

SWAV vs. DOCS - Financials Comparison

This section allows you to compare key financial metrics between ShockWave Medical, Inc. and Doximity, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


50.00M100.00M150.00M200.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
218.81M
185.05M
(SWAV) Total Revenue
(DOCS) Total Revenue
Values in USD except per share items